Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W M Johnson

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Hematological Oncology|June 8, 2017
Response-adapted therapy in Hodgkin lymphomaJack Broadfoot, Peter W M Johnson
Chinese Clinical Oncology|April 6, 2015
Risk- and response-adapted strategies for the management of Hodgkin lymphomaMarcus Remer, Peter W M Johnson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Harnessing innate immunity to suppress lymphomaFreda K Stevenson, Peter W M Johnson
Seminars in Hematology|August 7, 2016
Treatment of advanced-stage Hodgkin lymphomaTheodoros P Vassilakopoulos, Peter W M Johnson
Drug Discovery Today|April 12, 2012
Stratified medicine for cancer therapyEmily C Shaw, Peter W M Johnson
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 12, 2017
<sup>18</sup>F-FDG PET/CT in Lymphoma: Has Imaging-Directed Personalized Medicine Become a Reality?Sally F Barrington, Peter W M Johnson
Blood|March 4, 2018
Optimizing therapy in advanced-stage Hodgkin lymphomaSean H Lim, Peter W M Johnson
Best Practice & Research. Clinical Haematology|December 7, 2002
Molecular remission and non-Hodgkin's lymphomaAngela J Darby, Peter W M Johnson
Nature Reviews. Clinical Oncology|September 7, 2011
Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cureSean H Lim, Peter W M Johnson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2025
Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older PatientsVivek S Radhakrishnan, Peter W M Johnson
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Hematological Oncology|June 8, 2017
Response-adapted therapy in Hodgkin lymphomaJack Broadfoot, Peter W M Johnson
Chinese Clinical Oncology|April 6, 2015
Risk- and response-adapted strategies for the management of Hodgkin lymphomaMarcus Remer, Peter W M Johnson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Harnessing innate immunity to suppress lymphomaFreda K Stevenson, Peter W M Johnson
Seminars in Hematology|August 7, 2016
Treatment of advanced-stage Hodgkin lymphomaTheodoros P Vassilakopoulos, Peter W M Johnson
Drug Discovery Today|April 12, 2012
Stratified medicine for cancer therapyEmily C Shaw, Peter W M Johnson
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 12, 2017
<sup>18</sup>F-FDG PET/CT in Lymphoma: Has Imaging-Directed Personalized Medicine Become a Reality?Sally F Barrington, Peter W M Johnson
Blood|March 4, 2018
Optimizing therapy in advanced-stage Hodgkin lymphomaSean H Lim, Peter W M Johnson
Best Practice & Research. Clinical Haematology|December 7, 2002
Molecular remission and non-Hodgkin's lymphomaAngela J Darby, Peter W M Johnson
Nature Reviews. Clinical Oncology|September 7, 2011
Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cureSean H Lim, Peter W M Johnson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2025
Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older PatientsVivek S Radhakrishnan, Peter W M Johnson
Pageof 11